Increase in 483s, Warnings Highlights Need to Improve Supplier Controls

There has been a steady uptick in the number of FDA 483s that cite inadequate supplier controls — from 84 in 2011, to 110 in 2012 and 126 last year. The problem is now one of the top five most common 483 findings for devicemakers.
The GMP Letter